Cargando…

Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells

Specific recognition of circulating tumor cells (CTCs) is of great significance for cancer diagnosis and personalized therapy. The antibodies and aptamer are commonly used for recognition of CTCs, but they often suffer from low stability and high cost. Therefore, chemically stable and low-cost artif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Wang, Jiaoyang, Li, Ping, Wu, Chuanchen, Zhang, Hongyan, Zhang, Wen, Wang, Hui, Tang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579199/
https://www.ncbi.nlm.nih.gov/pubmed/28860472
http://dx.doi.org/10.1038/s41598-017-10486-9
_version_ 1783260663000334336
author Zhang, Wei
Wang, Jiaoyang
Li, Ping
Wu, Chuanchen
Zhang, Hongyan
Zhang, Wen
Wang, Hui
Tang, Bo
author_facet Zhang, Wei
Wang, Jiaoyang
Li, Ping
Wu, Chuanchen
Zhang, Hongyan
Zhang, Wen
Wang, Hui
Tang, Bo
author_sort Zhang, Wei
collection PubMed
description Specific recognition of circulating tumor cells (CTCs) is of great significance for cancer diagnosis and personalized therapy. The antibodies and aptamer are commonly used for recognition of CTCs, but they often suffer from low stability and high cost. Therefore, chemically stable and low-cost artificial recognition elements are still highly demanded. Herein, we prepared nano artificial antibody based on molecular imprinting and applied for fluorescence recognition of CTCs. Surface imprinting was employed to construct a transferrin (TRA)-imprinted layer on the surface of rhodamine doped silica nanoparticles. Take advantage of the specific interaction between TRA and TRA receptor (overexpressed on cancer cells), the as-prepared TRA-imprinted artificial antibody was allowed for specific targeting cancer cells mediated by TRA. And the average recognition efficiency of the artificial antibody for the cancer cells was 88% through flow cytometry. Finally, the nano artificial antibody was successfully applied to specific identify mimetic CTCs, under the same conditions, the recognition ability of artificial antibody for CTCs was 8 times higher than the white blood cells.
format Online
Article
Text
id pubmed-5579199
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55791992017-09-06 Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells Zhang, Wei Wang, Jiaoyang Li, Ping Wu, Chuanchen Zhang, Hongyan Zhang, Wen Wang, Hui Tang, Bo Sci Rep Article Specific recognition of circulating tumor cells (CTCs) is of great significance for cancer diagnosis and personalized therapy. The antibodies and aptamer are commonly used for recognition of CTCs, but they often suffer from low stability and high cost. Therefore, chemically stable and low-cost artificial recognition elements are still highly demanded. Herein, we prepared nano artificial antibody based on molecular imprinting and applied for fluorescence recognition of CTCs. Surface imprinting was employed to construct a transferrin (TRA)-imprinted layer on the surface of rhodamine doped silica nanoparticles. Take advantage of the specific interaction between TRA and TRA receptor (overexpressed on cancer cells), the as-prepared TRA-imprinted artificial antibody was allowed for specific targeting cancer cells mediated by TRA. And the average recognition efficiency of the artificial antibody for the cancer cells was 88% through flow cytometry. Finally, the nano artificial antibody was successfully applied to specific identify mimetic CTCs, under the same conditions, the recognition ability of artificial antibody for CTCs was 8 times higher than the white blood cells. Nature Publishing Group UK 2017-08-31 /pmc/articles/PMC5579199/ /pubmed/28860472 http://dx.doi.org/10.1038/s41598-017-10486-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zhang, Wei
Wang, Jiaoyang
Li, Ping
Wu, Chuanchen
Zhang, Hongyan
Zhang, Wen
Wang, Hui
Tang, Bo
Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title_full Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title_fullStr Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title_full_unstemmed Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title_short Transferrin-navigation Nano Artificial Antibody Fluorescence Recognition of Circulating Tumor Cells
title_sort transferrin-navigation nano artificial antibody fluorescence recognition of circulating tumor cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579199/
https://www.ncbi.nlm.nih.gov/pubmed/28860472
http://dx.doi.org/10.1038/s41598-017-10486-9
work_keys_str_mv AT zhangwei transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT wangjiaoyang transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT liping transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT wuchuanchen transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT zhanghongyan transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT zhangwen transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT wanghui transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells
AT tangbo transferrinnavigationnanoartificialantibodyfluorescencerecognitionofcirculatingtumorcells